Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with α-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure
Bucklay, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.J.; Macgregor, G.A.
Clinical Science (1979) 77(5): 573-579
1989
ISSN/ISBN: 0143-5221 Accession: 075832156
Full Text Article emailed within 1 workday: $29.90
Related References
Buckley, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.J.; MacGregor, G.A. 1989: Immunoreactive N -terminal Pro-Atrial Natriuretic Peptide in Human Plasma: Plasma Levels and Comparisons with -Human Atrial Natriuretic Peptide in Normal Subjects, Patients with Essential Hypertension, Cardiac Transplant and Chronic Renal Failure Clinical Science 77(5): 573-579Buckley, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.; MacGregor, G.A. 1989: Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure Clinical Science 77(5): 573-579
Bruckley, M.G.; Sagnella, G.A.; Markandu, N.D.; Singer, D.R.J.; Macgregor, G.A. 1989: Immunoreactive amino terminal pro atrial natriuretic peptide in human plasma plasma levels and comparisons with alpha human atrial natriuretic peptide in normal subjects patients with essential hypertension cardiac transplant and chronic renal failure Clinical Science 77(5): 573-579
Buckley, M.G.; Sethi, D.; Jennison, H.; Eastwood, J.B.; Markandu, N.D.; Sagnella, G.A.; Singer, D.R.J.; Macgregor, G.A. 1992: Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects cardiac transplant recipients and patients with chronic renal failure Clinical Science 82(3): 29P
Buckley, M.G.; Sethi, D.; Markandu, N.D.; Sagnella, G.A.; Singer, D.R.; MacGregor, G.A. 1992: Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure Clinical Science 83(4): 437-444
Buckley, M.G.; Sethi, D.; Markandu, N.D.; Sagnella, G.A.; Singer, D.R.J.; Macgregor, G.A. 1992: Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure Clinical Science (1979) 83(4): 437-444
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A. 1994: N-Terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma Investigation of plasma levels and molecular circulating form using radioimmunoassays for pro-atrial natriuretic peptide , pro-atrial natriuretic peptide and atrial natriuretic peptide Clinical Science 87(3): 311-317
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; MacGregor, G.A. 1994: N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma: investigation of plasma levels and molecular circulating form(s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67), pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126) Clinical Science 87(3): 311-317
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A. 1994: N-terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma : investigation of plasma levels and molecular circulating form(s) using radioimmunoassays for pro-atrial natriuretic peptide (31-67), pro-atrial natriuretic peptide (1-30) and atrial natriuretic peptide (99-126) Clinical Science (1979) 87(3): 311-317
Buckley, M; Markandu, N; Sagnella, G; MacGregor, G 1992: Plasma Concentrations and Comparisons of Brain Natriuretic Peptide and Atrial Natriuretic Peptide in Normal Subjects and Patients with Essential Hypertension Clinical Science 82(S26): 29p.3-29p
Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Mcgregor, G.A. 1992: Plasma concentrations of brain natriuretic peptide and atrial natriuretic peptide in normal subjects and patients with essential hypertension Clinical Science 82(3): 29P
Nishikimi, T.; Mori, Y.; Ishimura, K.; Tadokoro, K.; Yagi, H.; Yabe, A.; Horinaka, S.; Matsuoka, H. 2004: Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function American Journal of Medicine 116(8): 517-523
Buckley, M.G.; Markandu, N.D.; Miller, M.A.; Sagnella, G.A.; MacGregor, G.A. 1993: Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension Journal of Human Hypertension 7(3): 245-250
Predel, H.G.; Baecker, A.; Kipnowski, J.; Duesing, R.; Kramer, H.J. 1987: Relationship of plasma concentrations of immunoreactive human atrial natriuretic peptide ir hanp to renal function and blood pressure bp in chronic renal failure European Journal of Clinical Investigation 17(2 Part 2): A35
Hülsmann, M.; Berger, R.; Mörtl, D.; Gore, O.; Meyer, B.; Pacher, R. 2005: Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide European Journal of Heart Failure 7(4): 552-556
Boomsma, F.; Bhaggoe, U.M.; Man in 't Veld, A.J.; Schalekamp, M.A. 1996: Comparison of N-terminal pro-atrial natriuretic peptide and atrial natriuretic peptide in human plasma as measured with commercially available radioimmunoassay kits Clinica Chimica Acta; International Journal of Clinical Chemistry 252(1): 41-49
Predel, H.G.; Kipnowski, J.; Bäcker, A.; Stelkens, H.; Jürgens, U.; Düsing, R.; Kramer, H.J. 1988: Elevated plasma levels and heterogeneity of human atrial natriuretic peptide in patients with progressive chronic renal failure Zeitschrift für Kardiologie 77(Suppl 2): 65-71
Fulgheri, P.D.; Palermo, R.; Catalini, R.; D.N.to G.; Conti, V.; Ganzetti, S.; Rappelli, A. 1988: Plasma atrial natriuretic peptide in essential hypertension and in normal subjects European Heart Journal 9(ABSTR Suppl 1): 72
Morimoto, A.; Nishikimi, T.; Takaki, H.; Okano, Y.; Omae, T.; Matsuoka, H.; Kangawa, K.; Matsuo, H.; Kitamura, K.; Etoh, T. 1995: Effect of exercise of plasma adrenomedullin, atrial natriuretic peptide, and brain natriuretic peptide levels in patients with essential hypertension and ischaemic heart disease European Heart Journal 16(ABSTR Suppl ): 65
Morris, M.; Cain, M.; Russell, A.; Elliott, J.; Chalmers, J. 1987: Direct Radioimmunoassay of Human Plasma Atrial Natriuretic Peptide in Various Normal and Pathophysiological States: Increase in Renal and Cardiac Failure During Exercise Clinical and Experimental Hypertension a9(4): 703-718